Abstract
Contaminated surfaces make an important contribution to the transmission of several important pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and a number of resistant Gram-negative rods, including Acinetobacter baumannii. Several different approaches are available for improving hospital hygiene, including improving the effectiveness of existing methods and a range of new approaches, including novel disinfectants. A complimentary approach is the introduction of antimicrobial surfaces (AMS), which exert a continuous reduction on the level of microbial contamination on hospitals surfaces. There are several approaches to making a hospital surface ‘antimicrobial’: permanently ‘manufacture in’ an agent with antimicrobial activity; periodically apply an agent with antimicrobial activity; or physically alter the properties of a surface to make it less able to support microbial contamination and/or easier to clean. Promising options for AMS in healthcare settings include metals (principally copper or silver), chemicals (organosilanes, quaternary ammonium compounds, light-activated antimicrobials, and polycationic polymers) and physical alteration of the surface to reduce microbial attachment or improve cleanability. Before widespread adoption of AMS, promising candidates require rigorous in vitro and in situ assessment, including an evaluation of their clinical impact and cost effectiveness. Copper alloy surfaces are the most closely evaluated option for AMS, and have demonstrated in vitro activity against a range of pathogens (although their sporicidal capacity remains equivocal), evidence of efficacy in in situ studies and their introduction has been associated with a reduction in healthcare-associated infections (HAI). However, their long-term durability, acceptability and cost-effectiveness have not been evaluated formally. Finding and evaluating the optimal AMS will require a multidisciplinary approach, involving industrial partners, materials scientists, healthcare scientists and epidemiologists to refine and test the available options.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AMS:
-
Antimicrobial surfaces
- CFU:
-
Colony forming units
- DLC:
-
Diamond-like carbon
- EPA:
-
Environmental Protection Agency
- HAI:
-
Healthcare-associated infections
- HPV:
-
Hydrogen peroxide vapour
- ICU:
-
Intensive care unit
- MDRO:
-
Multidrug-resistant organisms (MDROs)
- MRSA:
-
Methicillin-resistant Staphylococcus aureus
- PEG:
-
Polyethylene glycol
- PHMB:
-
Polyhexamethylene biguanide
- QAC:
-
Quaternary ammonium compound
- R-GNR:
-
Resistant Gram-negative rods (R-GNR)
- TAC:
-
Total aerobic count
- VRE:
-
Vancomycin-resistant enterococci
References
Maki DG, Alvarado CJ, Hassemer CA, Zilz MA (1982) Relation of the inanimate hospital environment to endemic nosocomial infection. N Engl J Med 307:1562–1566
Otter JA, Yezli S, French GL (2011) The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 32:687–699
Manian FA, Griesenauer S, Senkel D et al (2011) Isolation of Acinetobacter baumannii complex and methicillin-resistant Staphylococcus aureus from hospital rooms following terminal cleaning and disinfection: can we do better? Infect Control Hosp Epidemiol 32:667–672
French GL, Otter JA, Shannon KP, Adams NM, Watling D, Parks MJ (2004) Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 57:31–37
Boyce JM, Havill NL, Otter JA et al (2008) Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 29:723–729
Boyce JM, Havill NL, Otter JA, Adams NM (2007) Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol 28:1142–1147
Lee BY, Wettstein ZS, McGlone SM et al (2010) Economic value of norovirus outbreak control measures in healthcare settings. Clin Microbiol Infect 17:640–646
Lawley TD, Clare S, Deakin LJ et al (2010) Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol 76:6895–6900
Oelberg DG, Joyner SE, Jiang X, Laborde D, Islam MP, Pickering LK (2000) Detection of pathogen transmission in neonatal nurseries using DNA markers as surrogate indicators. Pediatrics 105:311–315
Boyce JM (1998) Are the epidemiology and microbiology of methicillin-resistant Staphylococcus aureus changing? JAMA 279:623–624
Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA (2008) Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients’ environment. Infect Control Hosp Epidemiol 29:149–154
Otter JA, French GL (2009) Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol 47:205–207
Drees M, Snydman D, Schmid C et al (2008) Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 46:678–685
Shaughnessy MK, Micielli RL, DePestel DD et al (2011) Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 32:201–206
Huang SS, Datta R, Platt R (2006) Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 166:1945–1951
Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A (2011) Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the ICU. Clin Microbiol Infect 17:1201–1208
Hardy KJ, Oppenheim BA, Gossain S, Gao F, Hawkey PM (2006) A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients’ acquisition of MRSA. Infect Control Hosp Epidemiol 27:127–132
Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW (1996) Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 100:32–40
Passaretti CL, Otter JA, Reich NG et al (2013) An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 56:27–35
Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA (2006) Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 42:1552–1560
Datta R, Platt R, Yokoe DS, Huang SS (2011) Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med 171:491–494
Dancer SJ, White LF, Lamb J, Girvan EK, Robertson C (2009) Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 7:28
Mayfield JL, Leet T, Miller J, Mundy LM (2000) Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 31:995–1000
Donskey CJ (2013) Does improving surface cleaning and disinfection reduce health care-associated infections? Am J Infect Control 41:S12–S19
Denton M, Wilcox MH, Parnell P et al (2004) Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect 56:106–110
Zanetti G, Blanc DS, Federli I et al (2007) Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination. Infect Control Hosp Epidemiol 28:723–725
Thornley CN, Emslie NA, Sprott TW, Greening GE, Rapana JP (2011) Recurring norovirus transmission on an airplane. Clin Infect Dis 53:515–520
Martinez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR (2003) Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163:1905–1912
Stiefel U, Cadnum JL, Eckstein BC, Guerrero DM, Tima MA, Donskey CJ (2011) Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients. Infect Control Hosp Epidemiol 32:185–187
Kramer A, Schwebke I, Kampf G (2006) How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130
Salgado CD, Sepkowitz KA, John JF et al (2013) Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol 34:479–486
White LF, Dancer SJ, Robertson C, McDonald J (2008) Are hygiene standards useful in assessing infection risk? Am J Infect Control 36:381–384
Otter JA, Yezli S, Perl TM, Barbut F, French GL (2013) Is there a role for “no-touch” automated room disinfection systems in infection prevention and control? J Hosp Infect 83:1–13
Larson HE, Borriello SP (1990) Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters. Antimicrob Agents Chemother 34:1348–1353
Yezli S, Otter JA (2011) Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment. Food Environ Microbiol 3:1–30
Morter S, Bennet G, Fish J et al (2011) Norovirus in the hospital setting: virus introduction and spread within the hospital environment. J Hosp Infect 77:106–112
Dancer SJ (2004) How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect 56:10–15
Walder M, Holmdahl T (2012) Reply to Roberts. Infect Control Hosp Epidemiol 33:312–313
Roberts CG (2012) Hydrogen peroxide vapor and aerosol room decontamination systems. Infect Control Hosp Epidemiol 33:312
Mulvey D, Redding P, Robertson C et al (2011) Finding a benchmark for monitoring hospital cleanliness. J Hosp Infect 77:25–30
Boyce JM, Havill NL, Dumigan DG, Golebiewski M, Balogun O, Rizvani R (2009) Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol 30:678–684
Lewis T, Griffith C, Gallo M, Weinbren M (2008) A modified ATP benchmark for evaluating the cleaning of some hospital environmental surfaces. J Hosp Infect 69:156–163
Schmidt MG, Attaway HH, Sharpe PA et al (2012) Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J Clin Microbiol 50:2217–2223
Boyce JM, Havill NL, Havill HL, Mangione E, Dumigan DG, Moore BA (2011) Comparison of fluorescent marker systems with 2 quantitative methods of assessing terminal cleaning practices. Infect Control Hosp Epidemiol 32:1187–1193
Wilson AP, Smyth D, Moore G et al (2011) The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med 39:651–658
Moore G, Griffith C (2006) A laboratory evaluation of the decontamination properties of microfibre cloths. J Hosp Infect 64:379–385
McMullen KM, Zack J, Coopersmith CM, Kollef M, Dubberke E, Warren DK (2007) Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 28:205–207
Orenstein R, Aronhalt KC, McManus JE Jr, Fedraw LA (2011) A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol 32:1137–1139
Hardy KJ, Gossain S, Henderson N et al (2007) Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 66:360–368
Otter JA, Cummins M, Ahmad F, van Tonder C, Drabu YJ (2007) Assessing the biological efficacy and rate of recontamination following hydrogen peroxide vapour decontamination. J Hosp Infect 67:182–188
Carling PC, Parry MM, Rupp ME, Po JL, Dick B, Von Beheren S (2008) Improving cleaning of the environment surrounding patients in 36 acute care hospitals. Infect Control Hosp Epidemiol 29:1035–1041
Weber DJ, Rutala WA (2013) Self-disinfecting surfaces: review of current methodologies and future prospects. Am J Infect Control 41:S31–S35
Weber DJ, Rutala WA (2012) Self-disinfecting surfaces. Infect Control Hosp Epidemiol 33:10–13
Page K, Wilson M, Parkin IP (2009) Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem 19:3819–3831
Humphreys H (2014) Self-disinfecting and microbiocide-impregnated surfaces and fabrics: what potential in interrupting the spread of healthcare-associated infection? Clin Infect Dis 58:848–853.
O’Gorman J, Humphreys H (2012) Application of copper to prevent and control infection. Where are we now? J Hosp Infect 81:217–223
Grass G, Rensing C, Solioz M (2011) Metallic copper as an antimicrobial surface. Appl Environ Microbiol 77:1541–1547
Mijnendonckx K, Leys N, Mahillon J, Silver S, Van Houdt R (2013) Antimicrobial silver: uses, toxicity and potential for resistance. Biometals 26:609–621
Borkow G, Gabbay J (2008) Biocidal textiles can help fight nosocomial infections. Med Hypotheses 70:990–994
Wheeldon LJ, Worthington T, Lambert PA, Hilton AC, Lowden CJ, Elliott TS (2008) Antimicrobial efficacy of copper surfaces against spores and vegetative cells of Clostridium difficile: the germination theory. J Antimicrob Chemother 62:522–525
Tote K, Horemans T, Vanden Berghe D, Maes L, Cos P (2010) Inhibitory effect of biocides on the viable masses and matrices of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 76:3135–3142
Ojeil M, Jermann C, Holah J, Denyer SP, Maillard JY (2013) Evaluation of new in vitro efficacy test for antimicrobial surface activity reflecting UK hospital conditions. J Hosp Infect 85:274–281
EPA, Protocol # 01-1A. Protocol for residual self-sanitizing activity of dried chemical residues on hard, non-porous surfaces. http://www.epa.gov/oppad001/cloroxpcol_final.pdf. Accessed 14 Mar 2014
EPA, Test method for residual self-sanitizing activity of copper alloy surfaces. http://epa.gov/oppad001/pdf_files/test_meth_residual_surfaces.pdf. Accessed 14 Mar 2014
Monk AB, Kanmukhla K, Trinder K, Borkow G (2014) Potent bactericidal efficacy of copper oxide 3 impregnated non-porous solid surfaces. BMC Microbiol 14:57
Worthington T, Karpanen T, Casey A, Lambert P, Elliott T (2012) Reply to Weber and Rutala. Infect Control Hosp Epidemiol 33:645–646
Otter JA, Yezli S, Salkeld JA, French GL (2013) Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control 41:S6–S11
Hamilton D, Foster A, Ballantyne L et al (2010) Performance of ultramicrofibre cleaning technology with or without addition of a novel copper-based biocide. J Hosp Infect 74:62–71
Hedin G, Rynback J, Lore B (2010) Reduction of bacterial surface contamination in the hospital environment by application of a new product with persistent effect. J Hosp Infect 75:112–115
Schmidt MG, Attaway Iii HH, Fairey SE, Steed LL, Michels HT, Salgado CD (2013) Copper continuously limits the concentration of bacteria resident on bed rails within the intensive care unit. Infect Control Hosp Epidemiol 34:530–533
Casey AL, Adams D, Karpanen TJ et al (2010) Role of copper in reducing hospital environment contamination. J Hosp Infect 74:72–77
Boyce JM, Havill NL, Guercia KA, Schweon SJ, Moore BA (2014) Evaluation of two organosilane products for sustained antimicrobial activity on high-touch surfaces in patient rooms. Am J Infect Control 42:326–328
Casey AL, Karpanen TJ, Adams D et al (2011) A comparative study to evaluate surface microbial contamination associated with copper-containing and stainless steel pens used by nurses in the critical care unit. Am J Infect Control 39:e52–e54
Decraene V, Pratten J, Wilson M (2008) An assessment of the activity of a novel light-activated antimicrobial coating in a clinical environment. Infect Control Hosp Epidemiol 29:1181–1184
Ismail S, Perni S, Pratten J, Parkin I, Wilson M (2011) Efficacy of a novel light-activated antimicrobial coating for disinfecting hospital surfaces. Infect Control Hosp Epidemiol 32:1130–1132
Mikolay A, Huggett S, Tikana L, Grass G, Braun J, Nies DH (2010) Survival of bacteria on metallic copper surfaces in a hospital trial. Appl Microbiol Biotechnol 87:1875–1879
Taylor L, Phillips P, Hastings R (2009) Reduction of bacterial contamination in a healthcare environment by silver antimicrobial technology. J Infect Prev 10:6–12
Salgado CD, Sepkowitz KA, John JF et al (2013) Reply to Harbarth et al. Infect Control Hosp Epidemiol 34:997–999
Harbarth S, Maiwald M, Dancer SJ (2013) The environment and healthcare-acquired infections: why accurate reporting and evaluation of biological plausibility are important. Infect Control Hosp Epidemiol 34:996–997
Kuhn P (1983) Doorknobs: a source of nosocomial infection? Diagn Med Nov/Dec:62–63
Silver S, le Phung T (2005) A bacterial view of the periodic table: genes and proteins for toxic inorganic ions. J Ind Microbiol Biotechnol 32:587–605
Weaver L, Michels HT, Keevil CW (2008) Survival of Clostridium difficile on copper and steel: futuristic options for hospital hygiene. J Hosp Infect 68:145–151
Warnes SL, Highmore CJ, Keevil CW (2012) Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: implications for public health. MBio 3:e00489
Mkrtchyan HV, Russell CA, Wang N, Cutler RR (2013) Could public restrooms be an environment for bacterial resistomes? PLoS One 8:e54223
Molin S, Tolker-Nielsen T (2003) Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol 14:255–261
Airey P, Verran J (2007) Potential use of copper as a hygienic surface; problems associated with cumulative soiling and cleaning. J Hosp Infect 67:271–277
Santo CE, Morais PV, Grass G (2010) Isolation and characterization of bacteria resistant to metallic copper surfaces. Appl Environ Microbiol 76:1341–1348
Espirito Santo C, Taudte N, Nies DH, Grass G (2008) Contribution of copper ion resistance to survival of Escherichia coli on metallic copper surfaces. Appl Environ Microbiol 74:977–986
Hasman H, Aarestrup FM (2002) tcrB, a gene conferring transferable copper resistance in Enterococcus faecium: occurrence, transferability, and linkage to macrolide and glycopeptide resistance. Antimicrob Agents Chemother 46:1410–1416
Touati A, Zenati K, Brasme L, Benallaoua S, de Champs C (2010) Extended-spectrum beta-lactamase characterisation and heavy metal resistance of Enterobacteriaceae strains isolated from hospital environmental surfaces. J Hosp Infect 75:78–79
Gant VA, Wren MW, Rollins MS, Jeanes A, Hickok SS, Hall TJ (2007) Three novel highly charged copper-based biocides: safety and efficacy against healthcare-associated organisms. J Antimicrob Chemother 60:294–299
Luna VA, Hall TJ, King DS, Cannons AC (2010) Susceptibility of 169 USA300 methicillin-resistant Staphylococcus aureus isolates to two copper-based biocides, CuAL42 and CuWB50. J Antimicrob Chemother 65:939–941
EPA (2008) EPA registers copper-containing alloy products. http://www.epa.gov/pesticides/factsheets/copper-alloy-products.htm. Accessed 14 Mar 2014
EU (2013) Existing active substances for which a decision of non-inclusion into Annex I or Ia of Directive 98/8/EC has been adopted. http://ec.europa.eu/environment/chemicals/biocides/active-substances/non_inclusion_en.htm. Accessed 14 Mar 2014
Chaloupka K, Malam Y, Seifalian AM (2010) Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 28:580–588
Lorenzi SD, Romanini L, Finzi G, Salvatorelli G (2011) Biocide activity of microfiber mops with and without silver after contamination. Braz J Infect Dis 15:200–203
Brady MJ, Lisay CM, Yurkovetskiy AV, Sawan SP (2003) Persistent silver disinfectant for the environmental control of pathogenic bacteria. Am J Infect Control 31:208–214
Varghese S, Elfakhri S, Sheel DW, Sheel P, Bolton FJ, Foster HA (2013) Novel antibacterial silver-silica surface coatings prepared by chemical vapour deposition for infection control. J Appl Microbiol 115:1107–1116
Bright KR, Gerba CP, Rusin PA (2002) Rapid reduction of Staphylococcus aureus populations on stainless steel surfaces by zeolite ceramic coatings containing silver and zinc ions. J Hosp Infect 52:307–309
Cowan MM, Abshire KZ, Houk SL, Evans SM (2003) Antimicrobial efficacy of a silver-zeolite matrix coating on stainless steel. J Ind Microbiol Biotechnol 30:102–106
Isquith AJ, Abbott EA, Walters PA (1972) Surface-bonded antimicrobial activity of an organosilicon quaternary ammonium chloride. Appl Microbiol 24:859–863
Baxa D, Shetron-Rama L, Golembieski M et al (2011) In vitro evaluation of a novel process for reducing bacterial contamination of environmental surfaces. Am J Infect Control 39:483–487
Thom KA, Standiford HC, Johnson JK, Hanna N, Furuno JP (2014) Effectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical setting. Infect Control Hosp Epidemiol 35:1060–1062
Rutala WA, White MS, Gergen MF, Weber DJ (2006) Bacterial contamination of keyboards: efficacy and functional impact of disinfectants. Infect Control Hosp Epidemiol 27:372–377
Keward J (2013) Disinfectants in health care: finding an alternative to chlorine dioxide. Br J Nurs 22:928–932
Perni S, Piccirillo C, Pratten J et al (2009) The antimicrobial properties of light-activated polymers containing methylene blue and gold nanoparticles. Biomaterials 30:89–93
Decraene V, Pratten J, Wilson M (2008) Novel light-activated antimicrobial coatings are effective against surface-deposited Staphylococcus aureus. Curr Microbiol 57:269–273
Foster HA, Ditta IB, Varghese S, Steele A (2011) Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity. Appl Microbiol Biotechnol 90:1847–1868
Leng CW, Soe TA, Wui LW et al (2013) Efficacy of titanium dioxide compounds in preventing environmental contamination by meticillin resistant Staphylococcus aureus (MRSA). Int J Infect Control 9:1–8
Wilson M (2003) Light-activated antimicrobial coating for the continuous disinfection of surfaces. Infect Control Hosp Epidemiol 24:782–784
Smith K, Hunter IS (2008) Efficacy of common hospital biocides with biofilms of multi-drug resistant clinical isolates. J Med Microbiol 57:966–973
Russell AD (2004) Whither triclosan? J Antimicrob Chemother 53:693–695
Chung KK, Schumacher JF, Sampson EM, Burne RA, Antonelli PJ, Brennan AB (2007) Impact of engineered surface microtopography on biofilm formation of Staphylococcus aureus. Biointerphases 2:89–94
Reddy ST, Chung KK, McDaniel CJ, Darouiche RO, Landman J, Brennan AB (2011) Micropatterned surfaces for reducing the risk of catheter-associated urinary tract infection: an in vitro study on the effect of sharklet micropatterned surfaces to inhibit bacterial colonization and migration of uropathogenic Escherichia coli. J Endourol 25:1547–1552
Park KD, Kim YS, Han DK et al (1998) Bacterial adhesion on PEG modified polyurethane surfaces. Biomaterials 19:851–859
Hou S, Burton EA, Simon KA, Blodgett D, Luk YY, Ren D (2007) Inhibition of Escherichia coli biofilm formation by self-assembled monolayers of functional alkanethiols on gold. Appl Environ Microbiol 73:4300–4307
Hirota K, Murakami K, Nemoto K, Miyake Y (2005) Coating of a surface with 2-methacryloyloxyethyl phosphorylcholine (MPC) co-polymer significantly reduces retention of human pathogenic microorganisms. FEMS Microbiol Lett 248:37–45
Cheng G, Zhang Z, Chen S, Bryers JD, Jiang S (2007) Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials 28:4192–4199
Liu C, Zhao Q, Liu Y, Wang S, Abel EW (2008) Reduction of bacterial adhesion on modified DLC coatings. Colloids Surf B Biointerfaces 61:182–187
Shepherd SJ, Beggs CB, Smith CF, Kerr KG, Noakes CJ, Sleigh PA (2010) Effect of negative air ions on the potential for bacterial contamination of plastic medical equipment. BMC Infect Dis 10:92
Pangule RC, Brooks SJ, Dinu CZ et al (2010) Antistaphylococcal nanocomposite films based on enzyme-nanotube conjugates. ACS Nano 4:3993–4000
Markoishvili K, Tsitlanadze G, Katsarava R, Morris JG Jr, Sulakvelidze A (2002) A novel sustained-release matrix based on biodegradable poly(ester amide)s and impregnated with bacteriophages and an antibiotic shows promise in management of infected venous stasis ulcers and other poorly healing wounds. Int J Dermatol 41:453–458
Sileika TS, Barrett DG, Zhang R, Lau KHA, Messersmith PB (2013) Colorless multifunctional coatings inspired by polyphenols found in tea, chocolate, and wine. Angew Chem 52:10766–10770
Marais F, Mehtar S, Chalkley L (2010) Antimicrobial efficacy of copper touch surfaces in reducing environmental bioburden in a South African community healthcare facility. J Hosp Infect 74:80–82
Noyce JO, Michels H, Keevil CW (2006) Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment. J Hosp Infect 63:289–297
NHS, Smart solution for HCAI evaluation report: nanopool surface coating. http://www.trustech.org.uk/wp-content/uploads/2013/03/Nanopool-final-summary-v.3-FINAL.pdf. Accessed 14 Mar 2014
Karpanen TJ, Casey AL, Lambert PA et al (2012) The antimicrobial efficacy of copper alloy furnishing in the clinical environment: a crossover study. Infect Control Hosp Epidemiol 33:3–9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Otter, J.A. (2014). An Overview of the Options for Antimicrobial Hard Surfaces in Hospitals. In: Borkow, G. (eds) Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-08057-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-08057-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08056-7
Online ISBN: 978-3-319-08057-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)